1. Home
  2. ROAD vs JAZZ Comparison

ROAD vs JAZZ Comparison

Compare ROAD & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROAD
  • JAZZ
  • Stock Information
  • Founded
  • ROAD 2001
  • JAZZ 2003
  • Country
  • ROAD United States
  • JAZZ Ireland
  • Employees
  • ROAD N/A
  • JAZZ N/A
  • Industry
  • ROAD Engineering & Construction
  • JAZZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • ROAD Industrials
  • JAZZ Health Care
  • Exchange
  • ROAD Nasdaq
  • JAZZ Nasdaq
  • Market Cap
  • ROAD 5.5B
  • JAZZ 6.5B
  • IPO Year
  • ROAD 2018
  • JAZZ 2007
  • Fundamental
  • Price
  • ROAD $96.22
  • JAZZ $125.77
  • Analyst Decision
  • ROAD Buy
  • JAZZ Buy
  • Analyst Count
  • ROAD 4
  • JAZZ 14
  • Target Price
  • ROAD $71.50
  • JAZZ $173.93
  • AVG Volume (30 Days)
  • ROAD 424.5K
  • JAZZ 539.6K
  • Earning Date
  • ROAD 02-07-2025
  • JAZZ 11-06-2024
  • Dividend Yield
  • ROAD N/A
  • JAZZ N/A
  • EPS Growth
  • ROAD 39.36
  • JAZZ 458.10
  • EPS
  • ROAD 1.31
  • JAZZ 7.04
  • Revenue
  • ROAD $1,823,889,000.00
  • JAZZ $3,992,712,000.00
  • Revenue This Year
  • ROAD $41.62
  • JAZZ $7.51
  • Revenue Next Year
  • ROAD $10.72
  • JAZZ $6.82
  • P/E Ratio
  • ROAD $73.11
  • JAZZ $17.38
  • Revenue Growth
  • ROAD 16.65
  • JAZZ 5.23
  • 52 Week Low
  • ROAD $39.79
  • JAZZ $99.06
  • 52 Week High
  • ROAD $103.69
  • JAZZ $134.17
  • Technical
  • Relative Strength Index (RSI)
  • ROAD 49.87
  • JAZZ 56.71
  • Support Level
  • ROAD $92.67
  • JAZZ $121.73
  • Resistance Level
  • ROAD $97.11
  • JAZZ $126.23
  • Average True Range (ATR)
  • ROAD 3.38
  • JAZZ 2.79
  • MACD
  • ROAD -1.30
  • JAZZ -0.16
  • Stochastic Oscillator
  • ROAD 16.79
  • JAZZ 68.98

About ROAD Construction Partners Inc.

Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: